Clinical trial · Interventional
Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Surgeries
NCT04336917CI-TRIAL-00051345completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Postoperative analgesia after breast cancer surgery is a challenge for anesthesiologists due to the complex innervation of the breast. Interfascial plane blocks of the chest are gaining widespread popularity with the introduction of ultrasonography into the regional anesthesia practice. We aimed to investigate the efficacy of Rhomboid intercostal and subserratus plane block (RISS) for postoperative analgesia in patients undergoing breast cancer surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Surgery | — | UNRESOLVED | — |
| Postoperative Analgesia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Rhomboid Intercostal and Subserratus Plane Block with local anesthetic | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group Rhomboid Intercostal and Subserratus Plane Block
- description
- In addition to routine standard perioperative and postoperative analgesic protocol participants will recieve Rhomboid Intercostal and Subserratus Plane Block under ultrasound guidence at the end of the surgery.
- interventionNames
- Drug: Rhomboid Intercostal and Subserratus Plane Block with local anesthetic
- type
- NO_INTERVENTION
- label
- Control Group
- description
- Routine standard perioperative and postoperative analgesic protocol will be given.
Primary outcomes (1)
- measure
- Postoperative opiod consumption
- timeFrame
- The first 24 hours postoperatively
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients aged 18-85 years and ASA physiological score I-III who undergone breast cancer surgery Exclusion Criteria: * Patients refused to participate. * Patients with known or suspected allergy to the used medication. * Patients with psychiatric-neurological disorders that may affect pain perception, * Patients regularly taking antipsychotics and antidepressants. * Patients with potential risk of coagulopathy. * Uncooperative patients.
References
Publications (0)
Data not yet available
No reference posted for this study.